Read the latest insights on emerging CAR T therapies. This personalized treatment has shown promising results in certain types of cancers by harnessing the power of the immune system to fight disease.
An analysis of secondary outcomes from the KarMMA-3 trial (NCT03651128) have recently been published in the journal Lancet Hematology.